CNTN2 has been shown to promote glioma stem-like cell proliferation through regulation of EGFR-, HES1-, and APP/AICD-associated signaling pathways, and its knockdown suppresses tumor cell growth in vitro, supporting a functional role in glioblastoma progression [28,29]. Here, EGFR is linked to glioblastoma.